These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Haverkate F; Samama M Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and treatment of congenital fibrinogen deficiency. Peyvandi F Thromb Res; 2012 Dec; 130 Suppl 2():S7-11. PubMed ID: 23439004 [TBL] [Abstract][Full Text] [Related]
6. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group. Santacroce R; Cappucci F; Pisanelli D; Perricone F; Papa ML; Santoro R; Grandone E; Margaglione M Blood Coagul Fibrinolysis; 2006 Jun; 17(4):235-40. PubMed ID: 16651864 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of congenital fibrinogen disorders. Lebreton A; Casini A Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693 [TBL] [Abstract][Full Text] [Related]
9. [Life-long hemorrhagic diathesis in a young man with unclottable global coagulation tests--congenital afibrinogenemia]. Peter K; Furlan M; Lämmle B Ther Umsch; 1999 Sep; 56(9):516-8. PubMed ID: 10517123 [TBL] [Abstract][Full Text] [Related]
10. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders? Bevan DH Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651 [TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Miesbach W; Galanakis D; Scharrer I Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502 [TBL] [Abstract][Full Text] [Related]
12. Can the phenotype of inherited fibrinogen disorders be predicted? Casini A; de Moerloose P Haemophilia; 2016 Sep; 22(5):667-75. PubMed ID: 27293018 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias. Hill M; Dolan G Haemophilia; 2008 Sep; 14(5):889-97. PubMed ID: 18564189 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen and the risk of thrombosis. de Moerloose P; Boehlen F; Neerman-Arbez M Semin Thromb Hemost; 2010 Feb; 36(1):7-17. PubMed ID: 20391292 [TBL] [Abstract][Full Text] [Related]
15. [Obstetrical management in dysfibrinogenemia]. Heidegger H; Spannagel M; Schramm W Geburtshilfe Frauenheilkd; 1990 May; 50(5):365-7. PubMed ID: 2373333 [TBL] [Abstract][Full Text] [Related]
16. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects. Monaldini L; Asselta R; Duga S; Peyvandi F; Karimi M; Malcovati M; Tenchini ML Thromb Haemost; 2007 Apr; 97(4):546-51. PubMed ID: 17393016 [TBL] [Abstract][Full Text] [Related]
18. Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects. Miesbach W; Scharrer I; Henschen A; Neerman-Arbez M; Spitzer S; Galanakis D Blood Coagul Fibrinolysis; 2010 Jan; 21(1):35-40. PubMed ID: 19923982 [TBL] [Abstract][Full Text] [Related]
19. The molecular basis of quantitative fibrinogen disorders. Asselta R; Duga S; Tenchini ML J Thromb Haemost; 2006 Oct; 4(10):2115-29. PubMed ID: 16999847 [TBL] [Abstract][Full Text] [Related]
20. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]